![]() (speaker bureau), Dendreon (speaker bureau), Janssen (speaker bureau, current), Astellas WebMD (past) PD: Bayer (speaker bureau, consultancy), Pfizer (speaker bureau), Myovant Myovant (past), Accuray (past), Janssen TMS: Varian Medical Systems, CorTechs Labs, (past), Bayer Pharmaceuticals, Stratify Genomics, Specialty Networks RCC: Astellas, Of California San Diego from GE Healthcare.Ĭonflict of Interest: FDG: Labcorp, Urology Partners of America, Janssen Pharmaceuticals Support: TMS: In-kind research support to Department of Radiation Oncology, University Boston: Harvard Business School Press 2006. : Redefining Health Care: Creating Value-Based Competition on 2 Results. : Uptake of active surveillance for very-low-risk prostate cancer in Sweden. ![]() : Defining quality metrics for active surveillance: the Michigan Urological Surgery : Variation in guideline concordant active surveillance follow-up in diverse urology American Urological Association: AUA Quality Registry: 2016 QCDR Measures: PQRS Measures. Centers for Medicare & Medicaid Services: National Health Expenditures Fact Sheet. ![]() 114th Congress (2015-2016): H.R.2-Medicare Access and CHIP Reauthorization Act of 2015. Washington, DC: National Academies Press 2001. Institute of Medicine: Crossing the Quality Chasm: A New Health System for the 21st Century. : What is value in health care? N Engl J Med 2010 363: 2477.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |